“Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs),” Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post’s “Impact” blog. He asks, “So how well is the private sector doing in tackling the rising pandemic of NCDs, which cause nearly two out of every three deaths in the world (80 percent of those in developing countries), the four main ones being cancer, cardiovascular disease, chronic respiratory disease and diabetes?” He continues, “The private sector is a major stakeholder in many ways — as employers; makers of food and medicines, sports gear and technology; as corporate citizens and consumers — and wants to be engaged in the global NCD dialogue. We deserve a seat at the table.”
Though the global community has “made incredible inroads” on the Millennium Development Goals (MDGs), “the majority of developing countries are still expected to fall short of the MDG targets for reducing maternal and child mortality by 2015,” Carole Presern, director of the Partnership for Maternal, Newborn & Child Health (PMNCH), writes in the Huffington Post’s “Global Motherhood” blog. A report released recently by PMNCH “sheds light on the reasons why more progress is not being made to end these needless deaths” by examining “commitments made to advance the Global Strategy for Women’s and Children’s Health” launched by U.N. Secretary-General Ban Ki-moon in 2010, she notes.
U.S. Foreign Aid Critical To Achieving Health Goals, Improving Lives, Strengthening International Relationships
“Day after day, American foreign aid is dramatically improving millions of lives and consequently, impressions of America,” former New Jersey Governor Thomas Kean and Ray Chambers, chair of the MDG Health Alliance and the U.N. Secretary-General’s Special Envoy for Malaria, write in the Huffington Post’s “Global Motherhood” blog. For example, “[w]hen a mother in malaria prone sub-Saharan Africa puts her child to sleep under a mosquito net that Americans supported, America is building a relationship with that family” they state, noting, “Most Americans, when they realize that our investment in foreign assistance, at less than one percent of our GDP, can provide such transformative benefits, stand firmly behind this support, even in these more difficult economic times domestically.” The authors cite a recent Kaiser Family Foundation poll that showed two-thirds of respondents felt U.S. spending on global health was too little or about the right amount.
In this post in the Center for Global Development’s (CGD) “Global Health Policy” blog, Amanda Glassman, a senior fellow and director of global health policy at CGD, and Jenny Ottenhoff, a policy outreach associate at the center, discuss the closure of the Global Health Initiative (GHI) office and the creation of the Office of Global Health Diplomacy at the State Department, to be “led by an ambassador responsible for ‘champion[ing] the priorities and policies of the GHI in the diplomatic arena,'” according to the announcement. They list “a few roles a global health ambassador could play that may prove a ‘value add’ to the U.S. global health architecture,” and state, “The new ambassador will be entering the position with the deck stacked again them and will need to address many of the institutional constraints of the late GHI office, namely lack of formal budgetary, policy or legal leverage over the many U.S. agencies working in global health.” Noting a recent brief by the Kaiser Family Foundation says an ambassador for global health diplomacy could raise the profile of and provide new opportunities for addressing global health, the blog authors conclude, “[I]n an ever challenging political and fiscal environment, that may be exactly what U.S. global health programs need” (9/20).
The Bill & Melinda Gates Foundation’s “Impatient Optimists” blog continues its series, published in partnership with Women Deliver, to recognize World Contraception Day, observed annually on September 26. The following pieces were published recently:
Noting this week marks the first anniversary of the U.N. High-Level Meeting on Non-Communicable Diseases (NCDs), a Lancet editorial states, “The meeting was a crucial step for putting diseases such as cancer and cardiovascular disease high on the global health agenda. However, little action, other than more talking, has been taken since.” The editorial continues, “The key positive development of the past year was the goal to reduce preventable deaths from NCDs by 25 percent by 2025 passed by the World Health Assembly in May,” but “[t]he challenge now is how to meet it.”
“If left unaddressed, [non-communicable diseases (NCDs)] will lead to more death, disability and the implosion of already overburdened health systems in developing countries at huge cost to individuals, families, businesses and society,” Peter Piot, director of the London School of Hygiene and Tropical Medicine and former UNAIDS executive director, writes in the Huffington Post “Impact” blog, adding, “Like AIDS, NCDs are a problem for rich and poor countries alike, but the poor suffer the most.” He continues, “The 2011 U.N. High-Level Meeting on NCDs — only the second time the U.N. had convened a major meeting on a health issue, following the U.N. AIDS Summit in June 2001 — was a landmark event in the short history of the fight against NCDs but was not a tipping point. Much more remains to be done.”
In a post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Helen Matzger, a program officer in new vaccine delivery at the foundation, writes about outbreaks of cholera in Haiti, Sierra Leone, Guinea, and other areas, and says creating stockpiles of a recently WHO-approved cholera vaccine could help save lives in the future. “The creation of a cholera stockpile is not a panacea; … Still, the cholera vaccine works. Though many of us may never need it, millions of people living in some of the poorest regions of the world face cholera outbreaks all too often. We have a way to alter the course of an outbreak and save lives. Let’s use it,” she concludes (9/19).
Noting that “[n]on-communicable diseases (NCDs) kill four times the number of people in low- and middle-income countries (LMICs) that they do in high-income countries,” Benn Grover, a health communications specialist who manages policy for the National Forum for Heart Disease and Stroke Prevention, and Felicia Knaul, an associate professor at Harvard Medical School and director of the Harvard Global Equity Initiative, write in the Huffington Post Blog, “The right to health of the majority of the world’s inhabitants is severely hampered due to vast inequalities in access to care and many of the social rights that determine their health. These inequalities are not just a matter of health, but issues of social justice and human rights.”
Bill Gates Describes How 'Catalytic Philanthropy' Can Help Bring Vaccines, Medicines To Untouched Markets
In an essay adapted for Forbes magazine from a speech given at the Forbes 400 Summit on Philanthropy in June, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, discusses how “[i]nnovations for the poor suffer from … market limitations” and his idea of “catalytic philanthropy.” Gates writes, “The market is not going to place huge bets on research when there are no buyers for a breakthrough. This explains why we have no vaccine for malaria today, even though a million people die from it every year.” Therefore, “when you come to the end of the innovations that business and government are willing to invest in, you still find a vast, unexplored space of innovation where the returns can be fantastic,” he continues.